Ureteral Obstruction Owing to Endometriosis: Reversal with Synthetic Progestin

article OA: closed CC0 ⤵ 25 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-09

This case report details a patient with ureteral obstruction caused by endometriosis that completely resolved with synthetic progestin treatment, as confirmed by renal imaging and renograms.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A case of unilateral ureteral obstruction owing to extensive pelvic endometriosis is presented. There was complete resolution of ureteral obstruction following treatment with synthetic progestin. Sequential assessment of renal function was provided by renal imaging and renograms. It would appear that selected patients with obstructive uropathy may respond favorably to medical management, which would allow for preservation of reproductive capabilities and restoration of renal excretory function.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Progesterone Congeners Ureteral Obstruction Uterine Neoplasms Adult Dilatation, Pathologic Dilatation, Pathologic Dose-Response Relationship, Drug Endometriosis Endometriosis Ethinyl Estradiol Ethinyl Estradiol Female Humans Hydronephrosis Hydronephrosis Kidney Function Tests Lymphatic Metastasis Norgestrel Norgestrel

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (8)

Cited by (25)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-14T05:58:58.463083+00:00
License: CC0 · commercial use OK